{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-12T12:24:14.702103+00:00",
  "news": [
    {
      "title": "The Bull Case for Vertex Pharmaceuticals (VRTX) Could Change Following Strong Kidney Data and Regulatory Progress - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZjBOblp5SzRrVlRSaFJDSDRZX2M0X3BJdXgyVGEwVHJJUVNnbHJra2hBTTFSLVZFeVpfbFI2N1pPYVo3UkU2ZEVZRUdmdWdDdGhTcHd2MkhMTElYOFNUM2lWOHMzd1lvUFlWNHF2NDNMWU9VMFVuQ3hZbFRLdjVVNTlqd1VyZnJKa1Zr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZjBOblp5SzRrVlRSaFJDSDRZX2M0X3BJdXgyVGEwVHJJUVNnbHJra2hBTTFSLVZFeVpfbFI2N1pPYVo3UkU2ZEVZRUdmdWdDdGhTcHd2MkhMTElYOFNUM2lWOHMzd1lvUFlWNHF2NDNMWU9VMFVuQ3hZbFRLdjVVNTlqd1VyZnJKa1Zr?oc=5\" target=\"_blank\">The Bull Case for Vertex Pharmaceuticals (VRTX) Could Change Following Strong Kidney Data and Regulatory Progress</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-11T02:16:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030 - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5\" target=\"_blank\">Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-10-27T07:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Novartis, Vertex, More Optimizing Shots on Multiple Goals in Lucrative I&I Space - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOdUJJaGJCWVVlTWJnMU4wNnFZVjM3eGczZ3JrLVByV3hIY3FPeGVjTGpOQjJZWFBXRzhjYXNmYW05dWp1RF9Ta0EtYmdYeHlvM0hJcDgzaGlVZEVCMkdkWnh2aUFFQnJEOHFsOXFHSU5UX3o1UTdhdGZvckV2SEpELTVkaTNOQlRPTkJqTVlFWEgyZERnRHcxQmFocm81UzNENXI2b1R1UXVOLWR1Y1YxR193?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxOdUJJaGJCWVVlTWJnMU4wNnFZVjM3eGczZ3JrLVByV3hIY3FPeGVjTGpOQjJZWFBXRzhjYXNmYW05dWp1RF9Ta0EtYmdYeHlvM0hJcDgzaGlVZEVCMkdkWnh2aUFFQnJEOHFsOXFHSU5UX3o1UTdhdGZvckV2SEpELTVkaTNOQlRPTkJqTVlFWEgyZERnRHcxQmFocm81UzNENXI2b1R1UXVOLWR1Y1YxR193?oc=5\" target=\"_blank\">Novartis, Vertex, More Optimizing Shots on Multiple Goals in Lucrative I&amp;I Space</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-12T11:33:11+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals' (NASDAQ:VRTX) Performance Is Even Better Than Its Earnings Suggest - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQZEt6T3poOTY3NjduZ2h3WUxzQlRvTUoydXJ0TTdKUTZLOUZWMUU1N0RwNVB6UVVXQXdWLVNvYkNqRFVPNTNMaE1WeXFqekl1X1hsX19tN3lXTVRGY3I2V2FKRlR3RzBhVHhzYTJGM19RTHNGZkxZVEZvWlVlVTI3QUljWVgtUlpvUzBtenlfb1BtVldleEpMcXlkOGR6QnRmc3dXamxMWFVSeU5OZWpPa1lJbm85cHlMdlgtTWlpbHQtRXVYU0lyZ1ZfQzFzQmtILV9GWmNPY2o5ZktzaFJ2T1B0ejdzU0h4dzMweVhaN2RsQdIB8gFBVV95cUxQZEt6T3poOTY3NjduZ2h3WUxzQlRvTUoydXJ0TTdKUTZLOUZWMUU1N0RwNVB6UVVXQXdWLVNvYkNqRFVPNTNMaE1WeXFqekl1X1hsX19tN3lXTVRGY3I2V2FKRlR3RzBhVHhzYTJGM19RTHNGZkxZVEZvWlVlVTI3QUljWVgtUlpvUzBtenlfb1BtVldleEpMcXlkOGR6QnRmc3dXamxMWFVSeU5OZWpPa1lJbm85cHlMdlgtTWlpbHQtRXVYU0lyZ1ZfQzFzQmtILV9GWmNPY2o5ZktzaFJ2T1B0ejdzU0h4dzMweVhaN2RsQQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals' (NASDAQ:VRTX) Performance Is Even Better Than Its Earnings Suggest</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-11T11:45:25+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Vertex highlights growing Medicaid coverage for non-opioid painkiller Journavx (VRTX:NASDAQ) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNMTBweUozV2NXTHFhOWVEeFJDVnFLc0lpNGZ0SlVJX182MEt3YUhzYmxRZU5xSlhXMXVMUWZ2YVR2bHJkRzdZU0o3MUt0TlRQeU84alg3eFAwLTFjclJUcHFXSFlETmk3MzE3NS1RcC16a05EQ2tsaE12clFJcEY5OFk3NEhRUHJRcURqQUkxUzRxZ2h4djh4MnhGc1Fxa1o5d3VRV0N3Ul9aU3k0RHExa0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxNMTBweUozV2NXTHFhOWVEeFJDVnFLc0lpNGZ0SlVJX182MEt3YUhzYmxRZU5xSlhXMXVMUWZ2YVR2bHJkRzdZU0o3MUt0TlRQeU84alg3eFAwLTFjclJUcHFXSFlETmk3MzE3NS1RcC16a05EQ2tsaE12clFJcEY5OFk3NEhRUHJRcURqQUkxUzRxZ2h4djh4MnhGc1Fxa1o5d3VRV0N3Ul9aU3k0RHExa0pn?oc=5\" target=\"_blank\">Vertex highlights growing Medicaid coverage for non-opioid painkiller Journavx (VRTX:NASDAQ)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-11-11T18:01:03+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Home - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Home</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Why Vertex Skidded Despite Its Beat-And-Raise Quarter - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5\" target=\"_blank\">Why Vertex Skidded Despite Its Beat-And-Raise Quarter</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-11-04T21:13:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Vertex Pharmaceuticals: Hold Rating Amid High Valuation and Uncertain Growth Prospects Beyond Cystic Fibrosis - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQQ3Nsdkx0bUhXSmhaaW42bmstVUVMYVlxUjA3TDktZDhPNlpCeWpCd1BaRHRFRlF0OEFGUmRsRGkxcTh3YWRTMm52Rk5Qb01XTXhlRlEwRVFDTmNONXN0Tnc1eHhRZkloWGVVdlp0emMtRS1YSXRRQXEtc3R3bDE2OVpkbFp5YlpJdHBZeUt2cVlNWTVpUU81OGpZQy1XaDRQczZJVWc2NWQzQkpJdnBiakhLUmdiWEl4Nng0R2t5MjU5dkNPbnJXOUFVMGRBMjg2LVZSZlU0RGlXSUQxdGZwNjdOTmlybXlUZ3c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQQ3Nsdkx0bUhXSmhaaW42bmstVUVMYVlxUjA3TDktZDhPNlpCeWpCd1BaRHRFRlF0OEFGUmRsRGkxcTh3YWRTMm52Rk5Qb01XTXhlRlEwRVFDTmNONXN0Tnc1eHhRZkloWGVVdlp0emMtRS1YSXRRQXEtc3R3bDE2OVpkbFp5YlpJdHBZeUt2cVlNWTVpUU81OGpZQy1XaDRQczZJVWc2NWQzQkpJdnBiakhLUmdiWEl4Nng0R2t5MjU5dkNPbnJXOUFVMGRBMjg2LVZSZlU0RGlXSUQxdGZwNjdOTmlybXlUZ3c?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Hold Rating Amid High Valuation and Uncertain Growth Prospects Beyond Cystic Fibrosis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-11-11T15:49:59+00:00",
      "source": "TipRanks"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T10:55:06+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5\" target=\"_blank\">Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-11-03T08:00:00+00:00",
      "source": "Investing.com"
    },
    {
      "title": "VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5\" target=\"_blank\">VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2025-11-04T22:05:14+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-11-11",
      "close": 429.2200012207031
    },
    "history": [
      {
        "date": "2025-11-03",
        "close": 426.0
      },
      {
        "date": "2025-11-04",
        "close": 421.6700134277344
      },
      {
        "date": "2025-11-05",
        "close": 417.0
      },
      {
        "date": "2025-11-06",
        "close": 416.25
      },
      {
        "date": "2025-11-07",
        "close": 409.4700012207031
      },
      {
        "date": "2025-11-10",
        "close": 421.20001220703125
      },
      {
        "date": "2025-11-11",
        "close": 429.2200012207031
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}